Harnessing Large Language Models for Mental Health
Artificial intelligence is rapidly transforming mental health care. Consequently, Large Language Models (LLMs) play a key role in early screening, dig…
Artificial intelligence is rapidly transforming mental health care. Consequently, Large Language Models (LLMs) play a key role in early screening, dig…
Pacelli, A Former Executive of Dexcom, Inc., Will Lead Epitel Into Its Next Phase of GrowthSALT LAKE CITY--(BUSINESS WIRE)--#epilepsy--Epitel, Inc., a leader in AI technologies for patient-focused brain health solutions, is pleased to announce that St...
Company’s Radiology and Pathology Solutions Expand Clinician Capacity, Increase Operational Efficiency, and Improve Early Disease DiagnosisBOSTON--(BUSINESS WIRE)--Harrison.ai, a leading global healthtech company and developer of AI-powered medical di...
FDA clearance affirms Ibex’s position as a global leader in AI-powered cancer diagnosticsBOSTON--(BUSINESS WIRE)--Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, today announced that it has received U.S. Food and Drug Admin...
Expanding in a Multi-Trillion-Dollar market: DarioHealth (Nasdaq: DRIO) Taps into the $1.2 Trillion Cardiometabolic Market with New Blue Cross Blue Shield Agreement, which will utilize its AI-Driven Digital Health Platform which has shown a 58% Reduct...
HealthTech Startup Aims to Increase Access, Improve Standard of Care with AI NursePHOENIX--(BUSINESS WIRE)--Drive Health, a Phoenix-based digital health startup, announced today the launch of its revolutionary AI nurse in partnership with Google Publi...
SAN JOSE, Calif.--(BUSINESS WIRE)--VSee Health, Inc. (Nasdaq: VSEE), a leader in comprehensive digital health services and customized telehealth workflow streams, announces its $340K contract with a major EAP provider to build an integrated AI-enabled ...
Basel, Switzerland –28, January 2025 – Lyfegen, a global innovator in drug market access, pricing, and rebate management, has announced a transformat…
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today introduced a suite of new, transformative capabilities available in Tempus One, the company’s...
Bioptimus announces a $76M funding milestone, with the latest injection of $41M led by Cathay Innovation less than 12 months from its initial seed round Since the successful release of the largest AI foundation model for pathology in July, the comp...